Get started
Live feed
·
INSIDERFilingvia Quantisnow
Alaunos Therapeutics Inc. logo

CEO Weis Holger was granted 4,363 shares, increasing direct ownership by 21% to 25,483 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TCRTAlaunos Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TCRT (Alaunos Therapeutics Inc.) and more on Quantisnow.